期刊文献+

自体肝内移植类β细胞对糖尿病Beagle犬的长期疗效及安全性研究 被引量:2

Research of Long-term Curative Effects and the Security of the Autotransplantation of the Beta-like Cells in Diabetes Beagle Canines
原文传递
导出
摘要 目的探讨类β细胞自体肝内移植对糖尿病Beagle犬的长期疗效及安全性。方法通过逆转录病毒载体pMSCV将外源性胰岛素基因和EGFP基因转导入Beagle犬骨髓间充质干细胞(BMSCs),制备类β细胞。然后运用肝动脉介入技术,将类β细胞自体移植入糖尿病Beagle犬肝内,通过监测比较糖尿病Beagle犬移植前后各项生理指标,评价其是否具有长期稳定的治疗效果,同时进行肝脏生理功能及病理组织形态学检测,并对其生物安全性进行验证。结果自体移植类β细胞对糖尿病Beagle犬血糖、体质量、胰岛素水平均有明显改善(均P<0.01),且疗效持续80周以上;Beagle的肝功能正常(P>0.05),移植部位的肝脏未发现肿瘤形成,具有可靠的生物安全性。结论自体肝内移植类β细胞对Beagle犬糖尿病有长期疗效且具有相对可靠的生物安全性。 Objective To study the long-term curative effect and the security of the autotransplantation of the beta-like cells in diabetes Beagle canines.Methods BMSCs were isolated from the bone marrow of Beagle canine,expanded and transfected with a recombinant retrovirus MSCV carrying human insulin and EGFP genes.The hepatic artery involvement technology was utilized to transplant the beta-like cells to the live of diabetic Beagle canines.Each physiological norm was monitored before and after transplantation,and the long-term results of treatment were estimated.Simultaneously,the physiological function of liver and the pathology tectology examination were used to confirm the biological security.Results The autotransplantation of beta-like cells to diabetic Beagle canines made the blood glucose,the body weight,and the insulin level of the canines improve obviously,and the curative effect continued more than 80 weeks.The liver functions of the diabetic Beagle canines were normal.We have not discovered the formation of tumors in the transplant spot of liver.So it had the reliable biological security.Conclusion The autotransplantation of beta-like cells to diabetes Beagle canines had a long-term curative effect and relatively reliable biological security to the diabetes.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2011年第3期371-375,416,共6页 Suzhou University Journal of Medical Science
基金 国家自然科学基金资助项目(81070654)
关键词 类β细胞 制备 移植 糖尿病 BEAGLE犬 beta-like cell preparation transplantation diabetes Beagle canines
  • 相关文献

参考文献8

  • 1Xu Jian, Lu Yuhua, Ding Fei, et al. Reversal of diabetes in mice by intrahepatic injection of bone-derived GFP-mu- rine mesenchymal stem cells infected with the recombinant retrovirus-carrying human insulin gene[ J ]. World J Surg, 2007,31 (9) :1872 - 1882.
  • 2陆洋,陆玉华,王志伟,朱铭岩.转胰岛素基因的人骨髓间充质干细胞治疗大鼠糖尿病[J].苏州大学学报(医学版),2007,27(5):708-711. 被引量:8
  • 3陆玉华,朱铭岩,陈健,王志伟,钱海鑫.骨髓间充质干细胞在糖尿病小鼠体内的归巢及疗效观察[J].苏州大学学报(医学版),2009,29(3):436-438. 被引量:1
  • 4Dieren SV, Joline WJB, Schouw YT, et al. The global burden of diabetes and its complications : an emerging pan- demic[ J ]. European Journal of Cardiovascular Prevention & Rehabilitation, 2010,17 ( 1 ) : 3 - 8.
  • 5Vijay Y, Lawrence C. Minireview: β-cell replacement therapy for diabetes in the 21st century: manipulation of cell fate by directed differentiation[ J ]. Molecular Endocri-nology, 2010,24 (8) : 1501 - 1511.
  • 6Tolmaehov OE. Tightly-wound miniknot vectors for gene therapy: a potential improvement over supercoiled minicir- cle DNA[J]. Med Hypotheses,2010,74(4) : 702-704.
  • 7Starkey MP, Scase TJ, Mellersh CS,et al. Dogs really are man's best friend-canine genomics has applications in vet- erinary and human medicine [ J ]. Brief Funct Genomic Pro- teomic,2005,4(2) : 112 - 128.
  • 8Csaba L, Laszlo V, Tamas B, et al. Diabetes mellitus at- tenuates the repolarization reserve in mammalian heart[ J]. Cardiovasc Res, 2007,73(3) : 512 -520.

二级参考文献17

  • 1Dominici M, Le Blank K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells[J]. Cytotherapy, 2006,8(4):315-317.
  • 2Donald G, Darwin J. Concise review: mesenchymal stem/ multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views[J]. Stem Cells, 2007,25(11):2896 -2902.
  • 3Lu YH, Wang ZW, Zhu MY. Human bone marrow mesenchymal stem cells transfected with human insulin genes can secrete insulin stably[J]. Ann Clin Lab Sci,2006,36(2): 127-133.
  • 4Xu J, Lu YH, Ding F,et al. Reversal of diabetes in mice by intrahepatic injection of bone-derived GFP-murine mesenchymal stem cells infected with the recombinant retrovirus-carrying human insulin gene[J]. World J Surg, 2007, 31 (9): 1872-1882.
  • 5Adriana LP, Emeline M, Nathalie G, et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities[J]. Stem Cells, 2007,25(7):1737 -1745.
  • 6Mark A, Mohamed HS. Immunomodulation by mesenchymal stem cells A potential therapeutic strategy for type 1 diabetes[J]. Diabetes,2008,57(7):1759-1767.
  • 7Ryang HL, Min JS, Roxanne LR, et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD scid mice[J]. PNAS,2006, 103(46):17438-17443.
  • 8Yu Hua L,Zhi Wei W,MingYan Z. Human bone marrow mesenchymal stem cells transfected with human insulin genes can secrete insulin stably[J]. Annals of Clinical and Laboratory Science ,2006,36(2): 127-136.
  • 9Chan J,O'Donoghue K,Dela Fuente J,et al. Human fetal mesenchymal stem cells as vehicles for gene delivery[J]. Stem Cells, 2005,23(1) : 93-102.
  • 10Soria B,Roche E,Berna G,et al. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice[J]. Diabetes,2000,49 (2): 157-152.

共引文献7

同被引文献9

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部